Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pantagruel Partners is a private investment firm and venture capital vehicle based in London, focused on the life sciences and biotechnology sectors. The firm is closely affiliated with Medicxi, sharing key leadership including co-founder Francesco De Rubertis and partner Giovanni Mariggi. Pantagruel Partners specializes in the early-stage formation and financing of biotech companies, often utilizing an asset-centric investment model to develop specific therapeutic programs. It gained significant industry attention for its role as a founding investor in Centessa Pharmaceuticals, where it helped orchestrate the merger of ten distinct biotech startups into a single, unified entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pantagruel Partners.